Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Doxorubicin | 2 | 2023 | 329 | 0.930 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2023 | 281 | 0.830 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2023 | 576 | 0.790 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2023 | 596 | 0.730 |
Why?
|
| Cysts | 1 | 2020 | 109 | 0.620 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 179 | 0.570 |
Why?
|
| Liver Diseases | 1 | 2020 | 290 | 0.540 |
Why?
|
| Kidney Neoplasms | 1 | 2020 | 348 | 0.490 |
Why?
|
| Transplantation Conditioning | 3 | 2023 | 166 | 0.270 |
Why?
|
| Vincristine | 2 | 2023 | 108 | 0.260 |
Why?
|
| Cyclophosphamide | 2 | 2023 | 234 | 0.250 |
Why?
|
| Organoids | 1 | 2025 | 104 | 0.220 |
Why?
|
| Recurrence | 2 | 2023 | 1011 | 0.190 |
Why?
|
| Dexamethasone | 1 | 2023 | 350 | 0.180 |
Why?
|
| Transplantation, Homologous | 1 | 2022 | 402 | 0.180 |
Why?
|
| Disease-Free Survival | 1 | 2022 | 646 | 0.170 |
Why?
|
| Anilides | 1 | 2020 | 70 | 0.160 |
Why?
|
| Indazoles | 1 | 2020 | 66 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2023 | 14522 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 1560 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 611 | 0.140 |
Why?
|
| Pyrimidines | 1 | 2020 | 459 | 0.130 |
Why?
|
| Pyridines | 1 | 2020 | 478 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2020 | 497 | 0.130 |
Why?
|
| Lectins | 1 | 2015 | 48 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2015 | 86 | 0.120 |
Why?
|
| Adult | 5 | 2023 | 35599 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 2046 | 0.110 |
Why?
|
| Prognosis | 1 | 2022 | 3774 | 0.110 |
Why?
|
| Epitopes | 1 | 2015 | 472 | 0.100 |
Why?
|
| Neoplasm, Residual | 2 | 2023 | 121 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 877 | 0.090 |
Why?
|
| Neoplasms | 1 | 2025 | 2455 | 0.090 |
Why?
|
| Humans | 8 | 2025 | 129625 | 0.080 |
Why?
|
| Cytokines | 1 | 2015 | 2021 | 0.070 |
Why?
|
| Genetic Heterogeneity | 1 | 2025 | 58 | 0.060 |
Why?
|
| Etoposide | 1 | 2023 | 148 | 0.050 |
Why?
|
| Rituximab | 1 | 2023 | 164 | 0.050 |
Why?
|
| Prednisone | 1 | 2023 | 234 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2025 | 607 | 0.050 |
Why?
|
| Aged | 1 | 2020 | 22061 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2022 | 1159 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2023 | 1720 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 2015 | 24 | 0.030 |
Why?
|
| Monosaccharides | 1 | 2015 | 12 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2015 | 68 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2015 | 89 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2015 | 372 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 481 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 438 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2015 | 263 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2015 | 161 | 0.030 |
Why?
|
| Male | 1 | 2020 | 63670 | 0.030 |
Why?
|
| Ligands | 1 | 2015 | 621 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 843 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 698 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2057 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 2835 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 1491 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 2124 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 16961 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 35391 | 0.010 |
Why?
|